103 related articles for article (PubMed ID: 15711753)
1. Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men.
Undas A; Jankowski M; Twardowska M; Padjas A; Jakubowski H; Szczeklik A
Thromb Haemost; 2005 Feb; 93(2):346-50. PubMed ID: 15711753
[TBL] [Abstract][Full Text] [Related]
2. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Undas A; Kolarz M; Kopec G; Glowacki R; Placzkiewicz-Jankowska E; Tracz W
Nephrol Dial Transplant; 2007 Jun; 22(6):1685-9. PubMed ID: 17317712
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
Padjas A; Undas A; Swadzba J; Musiał J
Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity.
Nowakowska-Plaza A; Potaczek DP; Gluszko P; Undas A
Scand J Rheumatol; 2014; 43(1):17-21. PubMed ID: 24015711
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against Nε-homocysteinylated proteins in patients on different methods of renal replacement therapy.
Kolarz M; Małyszko J; Stompór T; Całka A; Undas A; Myśliwiec M
Clin Chem Lab Med; 2013 May; 51(5):1093-9. PubMed ID: 23183756
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis.
Undas A; Perła J; Lacinski M; Trzeciak W; Kaźmierski R; Jakubowski H
Stroke; 2004 Jun; 35(6):1299-304. PubMed ID: 15131313
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of Nε-homocysteinyl-lysine isopeptide in patients on long-term hemodialysis.
Kolarz M; Głowacki R; Stompór T; Wyroślak J; Undas A
Clin Chem Lab Med; 2012 Feb; 50(8):1373-8. PubMed ID: 22868801
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against N-homocysteinylated proteins and their determinants in patients on long-term hemodialysis.
Kolarz M; Wyroślak J; Zbróg Z; Kraśniak A; Rogulska J; Padjas A
Pol Arch Med Wewn; 2010 Jun; 120(6):223-30. PubMed ID: 20567206
[TBL] [Abstract][Full Text] [Related]
10. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease.
Jakubowski H
Clin Chem Lab Med; 2005; 43(10):1011-4. PubMed ID: 16197290
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice.
Perła-Kaján J; Stanger O; Luczak M; Ziółkowska A; Malendowicz LK; Twardowski T; Lhotak S; Austin RC; Jakubowski H
Biomed Pharmacother; 2008 Sep; 62(7):473-9. PubMed ID: 18501553
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
14. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
[TBL] [Abstract][Full Text] [Related]
17. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
18. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Balogh E; Bereczky Z; Katona E; Koszegi Z; Edes I; Muszbek L; Czuriga I
Thromb Res; 2012 Feb; 129(2):133-8. PubMed ID: 21803402
[TBL] [Abstract][Full Text] [Related]
19. Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
Nabipour I; Vahdat K; Jafari SM; Amiri M; Shafeiae E; Riazi A; Amini AL; Pazoki R; Sanjdideh Z
Heart Lung Circ; 2007 Dec; 16(6):416-22. PubMed ID: 17974477
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and progression of coronary artery disease.
Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
